Search Results: keywords:"pediatric cancer"

  • H. R. 3433 — An Act To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.
    Status:Engrossed in House
    Words:4,796

    H.R. 3433, known as the "Give Kids a Chance Act of 2024," aims to enhance pediatric cancer research and drug development by amending the Federal Food, Drug, and Cosmetic Act. The bill expands the responsibilities of the Food and Drug Administration (FDA) regarding pediatric cancer drugs,...

    Simple Explanation

    H.R. 3433, or the "Give Kids a Chance Act of 2024," is a plan to make medicines for kids with cancer better by changing some rules. It wants to make sure more research is done on kids' cancer drugs, changes some rules about rare disease drugs, and adds a new office to help with this work.

  • S. 4905 — To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.
    Status:Introduced in Senate
    Words:2,469

    The bill, known as the "Innovation in Pediatric Drugs Act of 2024," aims to update the Federal Food, Drug, and Cosmetic Act to improve the investigation of drugs targeting pediatric cancer. It proposes changes to ensure timely completion of pediatric study requirements and outlines penalties...

    Simple Explanation

    The bill aims to make it easier and quicker for kids with cancer to get special medicine by making new rules for testing these medicines. It wants to ensure that companies follow these rules and ask people about their opinions to make sure they work well for everyone.

  • H. R. 3433 — To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.
    Status:Reported in House
    Words:5,960

    H. R. 3433, known as the "Give Kids a Chance Act of 2024," aims to amend the Federal Food, Drug, and Cosmetic Act to improve the investigation of drugs for pediatric cancer by requiring specific targeted studies and enhancing FDA authority. It also extends the priority review voucher program...

    Simple Explanation

    The "Give Kids a Chance Act of 2024" is like making a new rulebook to help find better medicines for kids with cancer, making sure everyone involved works together nicely, and keeping everyone honest about sharing important findings.

  • S. 705 — To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.
    Status:Introduced in Senate
    Words:2,466

    The Innovation in Pediatric Drugs Act of 2025 aims to amend the Federal Food, Drug, and Cosmetic Act to improve the investigation of molecularly targeted drugs for pediatric cancer. It ensures that drug companies fulfill pediatric study requirements and outlines procedures...

    Simple Explanation

    The Innovation in Pediatric Drugs Act of 2025 is about making sure medicine for kids with cancer is researched and tested just like medicine for grown-ups, so it's safe and works well for them too. It also talks about how there should be money to help study these medicines and what happens if the companies don't follow the rules.

  • H. R. 1262 — To amend the Federal Food, Drug, and Cosmetic Act with respect to molecularly targeted pediatric cancer investigations, and for other purposes.
    💰
    Status:Introduced in House
    Words:5,298

    The H.R. 1262 bill, titled the "Give Kids a Chance Act of 2025," aims to modify rules related to pediatric cancer research and drug investigations under the Federal Food, Drug, and Cosmetic Act. It introduces requirements for studying drugs targeting pediatric cancers and...

    Simple Explanation

    The "Give Kids a Chance Act of 2025" is a bill that aims to help kids with cancer by encouraging more research to find better medicines, while also trying to make sure that research money is spent wisely. It also talks about collecting some fees to support organ transplants and creating better international partnerships for health safety.